calixlogoa19.jpg [calixlogoa19.jpg]
 
Exhibit 10.2

November 27, 2019

Michael Weening
[Redacted]
[Redacted]
[Redacted]

Re:    Relocation Allowance and Option Award Eligibility

Dear Michael:

The purpose of this letter is to confirm our recent discussions regarding your
eligibility to receive (i) additional cash compensation in the event you
relocate your principal place of employment to the Calix, Inc. (the “Company”)
offices located in San Jose, California, and (ii) additional equity
compensation.

The Company will provide you a quarterly relocation allowance in an amount equal
to $225,000 (the “Relocation Allowance”) during the period commencing January 1,
2020 and ending December 31, 2024, which will be paid, less applicable
deductions and withholdings, in a cash lump sum on the first payroll date of
each calendar quarter during such period. Notwithstanding the foregoing, you
acknowledge and agree that the Relocation Allowance will not be earned to any
extent unless you relocate your principal residence to the general vicinity of
the Company’s offices in San Jose, California on or prior to the first
anniversary of the date of this letter (the “Relocation Condition” and, the date
your relocation is complete, the “Relocation Date”) and will only be earned on
the Relocation Date if you remain continuously employed by the Company through
such date. If you fail to timely satisfy the Relocation Condition or if your
employment with the Company terminates for any reason prior to the Relocation
Date, you hereby agree to repay to the Company on the first anniversary of the
date of this letter or the date of termination, as applicable, the full amount
of the Relocation Allowance previously paid to you, and no additional Relocation
Allowance will be payable to you thereafter.

As an incentive for you to continue your employment with the Company and based
on other considerations, the Compensation Committee of the Company’s Board of
Directors (the “Committee”) has granted you an option under the Company’s 2019
Equity Incentive Award Plan (the “Plan”) to purchase 600,000 shares of the
Company’s Common Stock. Subject to your continued employment with the Company,
on each of the first four anniversaries of the date of this letter, you will
automatically be granted an additional option under the Plan (or any successor
thereto). In 2020, such option shall

Page 1 of 2

--------------------------------------------------------------------------------

calixlogoa16.jpg [calixlogoa16.jpg]

cover 300,000 shares of the Company’s Common Stock, and in each of 2021, 2022
and 2023, such option shall cover 120,000 shares of the Company’s Common Stock.

Each option will have an exercise price per share equal to the closing trading
price of a share of Company Common Stock on the date of grant (or the
immediately preceding trading day if the Company’s Common Stock is not traded on
the date of grant) and will

vest and become exercisable over four years, with 25% of each option vesting on
the first anniversary of the grant date of such option, and the remainder of the
option vesting in equal quarterly installments over three years (i.e., 6.25% of
the shares per quarter). Notwithstanding the foregoing, no shares issued upon
exercise of an option may be transferred in any manner prior to the second
anniversary of the date such shares vested, except for transfers effected by
will or by the laws of descent or distribution. Each option will otherwise be
subject to the Plan and the Company’s standard option agreement.

Nothing in this letter confers upon you any right to continued employment or
other service with the Company or interferes in any way with the at-will nature
of your employment. This letter is intended to supplement the offer of
employment from the Company to you dated May 20, 2016 (the “Offer Letter”). This
letter, together with the Offer Letter, constitutes the entire agreement between
the parties hereto with respect to the subject matter hereof and replaces and
supersedes any other agreements, arrangements, understandings or promises made
to you by anyone, whether oral or written, regarding the subject matter hereof.
In the event of any conflict between the terms of this letter and the Offer
Letter, the terms of this letter shall prevail.

Please indicate your acknowledgement and acceptance of the terms of this letter
by signing in the space indicated below and returning a signed copy of this
letter to me at your earliest convenience.

Sincerely,
Calix, Inc.

/s/ Carl Russo    
By: Carl Russo
Title: President and Chief Executive Officer

Accepted, Acknowledged and Agreed:

/s/ Michael Weening    
Michael Weening

Date: 11/29/2019    

Page 2 of 2